top of page

Welcome to Genando

Genando allows doctors and patients to choose the most suitable genetic test, receive clinically useful results from our experts and access personalised therapies.

Follow us!

  • LinkedIn
  • Facebook

WHAT WE DO

Genando Offers the only end-to-end medical genetic service available in the market

Focusing on congenital diseases, malformation and disabilities.

From standard screening tests to the innovative methods to diagnose and manage the hardest pregnancies.

Prevention and personalised therapies for some cancers in every organ.

From prevention to risk assessement for everyone in the family.

Improving drug effectiveness by creating a personalised therapy.

What we do

In Partnership with

BGenetica.png
Foundation Medicine.png
ATG_Logo_Default_Retina.png

HOW IT WORKS

Doctors identify the clinical need and choose the right test guided by Genando

Genando builds a clinical picture of the patient, analyses the DNA, interprets the results, makes a diagnosis and recommends personalised therapies

Patients receive easy to understand results and access to specialists if needed

Doctors

Genando Medical Genetics Platform

Patients

Genando Logo.jpg

Consultation and test selection

DNA sequencing and analysis

Clinical interpretation

Therapy recommendation

WHY GENANDO

Choosing the right test for you

AI algorithm that recommends the appropriate genetic test based on your clinical situation, personal and family medical history 

Doctors Recommend

“I've never worked with a geneticist, laboratory or clinic that was able to give me the same kind of insight as Genando. They were friendly, expert and warm.

Patients Recommend

“The transparency, explanations and friendliness of Genando were crucial in making me understand what was happening and what my options were.”

TESTIMONIALS

Contact Us

Email: info@genando.com

Phone: +39-055-674100

Address

Genando s.r.l.

Via Mannelli 15r (interno 9r)

50136, Florence, Italy

P.I.:06788020482

Aut.Comune di Firenze Provv. Dir.2019/DD/02831 del 05.04.2019

bottom of page